Sara Zawoyski
Analyst · Goldman Sachs. Please go ahead
Thank you, Beth. I'm pleased to share with you another quarter of strong execution with double-digit sales growth, return on sales expansion, and improved free cash. Let's turn to slide five to review our third quarter results. Sales of $745 million were up 16% compared to last year or 20% organically. Overall, sales growth was broad-based with double-digit growth across all segments and key verticals. Volume contributed -- continued to be strong, adding five points to growth and price adding 15 points. Foreign exchange was a four point headwind. Segment income was $144 million, up 22% with return on sales of 19.3% up 210 basis points sequentially and improved 90 basis points year-over-year, all better than expected. Volume and price contributions more than offset the impact from roughly $55 million of inflationary cost pressures, supply chain inefficiencies and FX headwinds. In addition, we continue to make investments in R&D, digital, and sales and marketing for growth and productivity. Q3 adjusted EPS was $0.66 up 25% year-over-year. We generated $126 million of free cash flow in the quarter, up 17%. We are actively managing working capital, while supporting robust demand in a challenging supply chain environment. We expect cash flow momentum to continue in the fourth quarter, reflecting our seasonal strength and working capital improvements. Now please turn to slide six for discussion of our third quarter segment performance, where you'll see continued sales momentum and strong margin performance. Starting with Enclosures, sales of $388 million increased 20% organically, with both volume and price contributing. Sales growth was broad-based across all verticals, led by infrastructure and industrial. Geographically, North America led followed by Europe. Overall, orders were up double-digits year-to-year. Enclosure's third quarter segment income was $72 million, up 27%. Return on sales improved 230 basis points sequentially and was up 170 basis points year-over-year to 18.5%. Improved execution and price realization offset the impact of inflation and continued supply chain inefficiencies. Recall this business was most impacted by inflation and supply chain challenges, and we pointed to ROS improvement in the back half of the year. We expect return on sales performance to continue to improve year-over-year in Q4 due to price/cost and improved productivity. Now moving to Electrical & Fastening, sales of $209 million increased 28% organically with both volume and price contributing. All verticals grew strong double-digits- led by infrastructure with power utilities up over 50%. Geographically, all regions grew led by North America. Orders were up double-digits in the quarter. Electrical & Fastening segment income was $61 million, up 26%. Return on sales was 29.1%, up 50 basis points relative to last year on strong execution and price offsetting inflation and supply chain headwinds. We continue to invest in new products and vertical teams to drive growth and support our customers. Turning to Thermal Management, sales of $148 million grew 13% organically with both volume and price contributing. All verticals grew double-digits, led by industrial with particular strength in chemicals. High margin industrial MRO demand continued to be robust for the sixth consecutive quarter. Geographically, North America was strongest with growth in MRO, chemicals and clean fuels. Europe saw strength in industrial, offset by the impact of Russia. China was down due to supply chain challenges and customer delays from COVID lockdowns. Overall, orders were flat in Q3 largely reflecting what we what impacted sales. We continued to see solid ordering quote activity for longer cycle projects. Thermal Management segment income was up 14% to $36 million. Return on sales expanded 140 basis points year-over-year to 24.2%, driven by improved price/cost and positive mix contribution from industrial MRO. Moving to slide seven, titled balance sheet and cash flow. We ended the quarter with a cash balance of $194 million. We focused on working capital improvements in Q3 and generated $126 million in free cash flow. Also, we exercised our delayed draw option on our $200 million term loan and ended the quarter with $600 million available on our revolver. We believe our healthy balance sheet provides us with ample capacity to invest in the business and execute on our growth strategy. Slide eight provides a summary of our capital allocation priorities. We continue to prioritize growth while maintaining a strong liquidity position. We ended the third quarter with a net debt to adjusted EBITDA ratio of 1.7 times, just below the low end of our target range of 2 to 2.5.Year-to-date, we have returned $96 million to shareholders, including a competitive dividend and share purchases. We believe our strong liquidity and robust cash flow position us well to continue to invest, execute on M&A and deliver attractive shareholder returns. Moving to slide nine, you will see our updated 2022 full year outlook. Our year-to-date performance has been strong, with sales up 21% and adjusted earnings per share up 18%. As Beth highlighted earlier, we are again raising our full year sales and earnings outlook. For organic sales growth, we now expect a range of 18% to 19% versus our prior guidance of 15% to 17% for the year. Adjusted EPS is expected to be in the range of $2.30 to $2.32 versus our prior guidance of $2.17 to $2.23. This new guidance reflects adjusted EPS growth of 17% to 18% on top of the 31% growth last year. For free cash flow, we now expect conversion to be approximately 90% at the low end of our prior range due to higher working capital to support our strong sales growth. A few other full year call outs, we now expect a four point FX headwind to the top line. Corporate cost expectations have moved up slightly to roughly $85 million and we now expect CapEx of approximately $50 million at the low end of our prior range. Looking at our fourth quarter outlook on slide 10, we expect reported sales to be up 4% to 6% and organic sales to be up 9% to 11% with an FX headwind of about 5%. We expect both volume and price to contribute. Our orders and backlog give us confidence in Q4 and into next year, and adjusted EPS is expected to be between $0.56 and $0.58. Wrapping up, we continue to execute well with strong sales growth, ROS expansion, and improved free cash flow. I am pleased with our performance and believe we are well-positioned for another great year. This concludes my remarks and I will now turn the call back over to Beth.